Blackstone and TPG Acquire Hologic in $18.3 Billion Healthcare Deal
Blackstone and TPG are acquiring women's health leader Hologic for up to $18.3 billion in one of 2025's largest healthcare buyouts, with shareholders receiving $76-$79 per share.
/ 1679 items
#XY↓
Galapagos Shuts Down Cell Therapy Division After Failed Sale Attempts
Biotech firm Galapagos winds down cell therapy business affecting 365 jobs across 5 countries after unsuccessful sale attempts. Stock drops 15% on announcement.
Elevance Health Beats Q3 Profit Expectations Despite Rising Medical Costs
Elevance Health surpasses Wall Street Q3 profit estimates with $6.03 adjusted EPS, managing medical costs better than expected despite ongoing healthcare industry challenges.
DocGo Stock Jumps 40% on SteadyMD Acquisition to Expand Telehealth Services
DocGo acquires virtual care platform SteadyMD for $25M, sending shares up 40%. The deal expands DocGo's telehealth capabilities across all 50 states as revenue declines.
Perspective Therapeutics Stock Plunges 29% Despite 'Remarkable' Safety Data from Cancer Drug Trial
Perspective Therapeutics shares fell 29% to $3.19 after presenting Phase 1/2a trial data for VMT-alpha-NET. Analysts split on outlook despite favorable safety profile and $174M cash position through late 2026.
Neuphoria's Social Anxiety Treatment Fails Phase 3 Trial
Neuphoria's AFFIRM-1 Phase 3 trial for BNC210 social anxiety treatment misses all endpoints. Company halts SAD program, reviews options.